Pharmaceuticals & Therapeutics

As RESTEM presents at BIO 2026, the company showcases its novel cell therapies aiming to reprogram the immune system, not just manage symptoms.

PawCo's arrival on Chewy is more than a distribution deal. It's a calculated move at the intersection of food science, AI, and sustainability.

Beyond the VivaTech hype, Rokid's strategic partnership with French retail giant Krys reveals a calculated plan to tackle AR's biggest adoption hurdles.

A new network aims to speed up clinical trials by recruiting patients from med spas and longevity clinics. Is this the future of medicine or a risky new frontier?

A Japanese tech firm is uniting global textile titans to reinvent wool. Discover how the 'PLATINUMWORLD' alliance is weaving a new industrial model.

Beyond new flavors, Beech-Nut’s latest launch is a calculated play for the modern parent, blending on-the-go convenience with key developmental milestones.

As overdose deaths skyrocket among Black and Indigenous communities, a new webinar confronts the systemic failures and charts a course for equitable care.

A new report reveals which cannabis brands dominate AI search, just as federal rescheduling creates chaos and opportunity. But with AI often refusing to answer, who wins?

With a novel FDA clearance for its at-home UVB device, Solius Labs isn't just launching a product; it's creating a new market for personalized medicine.

A landmark victory at the 2026 Autoflower World Cup validates 42 Fast Buds' strategic pivot to in-house cultivation, setting a new benchmark for the industry.

Hearst and NYU Langone's star-studded Health Lab reveals a strategic pivot from fitness to holistic wellness, tapping a new market of longevity and vulnerability.

Chronic fatigue, anxiety, and burnout are surging. A new wave of data-driven, integrative medicine claims to have the answer, moving beyond symptoms to the root cause.

Bristol Myers Squibb appoints Mayada Al-Ahmad, a 24-year pharma veteran, to lead its Saudi and Gulf operations, aligning with the region's ambitious health goals.

Forget perfect guidance. The future of stroke rehab may lie in making mistakes. Israel's Bioxtreme launches Dextreme 2.0, using AI to amplify errors and accelerate recovery.

A new partnership between Medventions and Mitacs aims to fix Canada's innovation gap by embedding engineers directly into clinics. Here's how it works.

A new partnership aims to replace needles with pills for a powerful class of drugs, using advanced AI to solve a multi-billion dollar challenge in medicine.

A Dutch medtech firm is advancing a pivotal study for its VCFix® system, a device that aims to reconstruct vertebrae rather than just fill them.

HPQ Silicon's new LOI aims to localize critical drone propulsion tech, but can a non-binding pact with French innovators truly break Asia's supply chain grip?

Gelteq aims to replace needles with its ingestible gel, targeting diabetes and more. But can it balance this lofty goal with near-term revenue and tight finances?

As federal support for science wanes, the National Cancer Center adds top minds from Stanford and Harvard to identify and fund the next wave of cancer cures.